CSL PLASMA
LIVE

Serial Number

97618260

Owner

CSL Limited

Attorney

Scott D. Woldow

Filing Date

Oct 4, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CSL PLASMA Trademark

Serial Number: 97618260

CSL PLASMA is a trademark filed by CSL Limited on October 4, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

CSL Limited (92 trademarks)

45 Poplar Road
Parkville, Victoria, 3052 , AU

Entity Type: 11

Trademark Details

Filing Date

October 4, 2022

Registration Date

Not Registered

Published for Opposition

January 2, 2024

Goods & Services

Treatment of biological products, namely, custom manufacturing and fractionation of blood; Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; production of reagents for immunohaematology laboratories for scientific or medical research use; processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; treatment of human blood and plasma; custom manufacturing of human blood and plasma

Insurance information and consultancy; charitable services, namely, providing financial support and financial information to patients and caregivers for obtaining medications, medical treatment, and access to care; Providing insurance information for patients diagnosed with medical conditions regarding medication access and reimbursement programs and insurance premium and co-pay assistance; providing insurance consulting services to patients diagnosed with medical conditions regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage; providing financial assistance programs to appropriate patients

Education services, namely, providing classes, seminars, and workshops in the field of continuing medical education and health education; Education services, namely, providing classes, seminars, and workshops in the field of blood plasma, donation of blood plasma and blood plasma conditions; Educational services, namely, providing online instruction in the field of health, medicine, pharmaceuticals and medical treatment via an online website; Educational services, namely, providing online instruction in the field of blood plasma and blood plasma conditions via an online website; Non-downloadable electronic publications, namely, newsletters in the field of health, medicine, pharmaceuticals and treatment; Non-downloadable electronic publications, namely, newsletters in the field of blood plasma and blood plasma conditions

Medical Research; Scientific Research in the field of medicines; Scientific Research and Development in the field of medicines; research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceutical preparations for gene therapy; Scientific Research in the field of blood plasma and blood plasma donation; Research and Development services in the fields of medicine, healthcare, blood conditions, gene and cell therapy, biotherapies and vaccines; Scientific and technological research, namely, scientific testing and screening services, in the nature of testing of human blood plasma for safety and quality; research and development of medical products, pharmaceutical products and blood products; new product research and development services; Laboratory analysis, namely, medical laboratory services and scientific laboratory services; Laboratory research services relating to pharmaceuticals and blood plasma; scientific testing and screening services, namely, testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma; Providing medical and scientific research information in the field of pharmaceuticals and blood plasma; Providing scientific information in the field of health care developments, blood plasma conditions, and new medical therapies; scientific information services in the field of health care developments, blood plasma conditions, and new medical therapies provided via the Internet; providing research information on donation of human blood for medical research

Promoting public awareness of blood diseases, illnesses and conditions; promoting awareness of vaccines and related illnesses; Promoting public awareness of blood plasma donation; Promoting the donation of blood and volunteer services and financial resources in the field of blood donations by means of arranging and conducting incentive reward programs; Providing information regarding medical billing support services, namely, medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 30, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jan 27, 2026 EX4G
SOU EXTENSION 4 FILED
Jan 27, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 27, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 28, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jul 28, 2025 EX3G
SOU EXTENSION 3 FILED
Jul 28, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 28, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jan 27, 2025 EX2G
SOU EXTENSION 2 FILED
Jan 27, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 27, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 29, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 29, 2024 EX1G
SOU EXTENSION 1 FILED
Jul 29, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 29, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 27, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 28, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 28, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 28, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 28, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 28, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 26, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 19, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2022 NWOS
NEW APPLICATION ENTERED
Oct 7, 2022 NWAP